Enter your login e-mail to the account
Search
Search parameters
Search results
- Victoza (liraglutid)
MUDr. Jitka Jurková
(4/2011, Drugs & drug classes ) - The choice of antidiabetic medications with regard to metabolic syndrome
doc. MUDr. Alena Šmahelová, PhD.
(11/2009, Review articles ) - GLITAZONES – PAST, PRESENT AND FUTURE
PharmDr. Tomáš Tesař, PhD., MBA, MUDr. Adriana Ilavská
(9/2008, clearly ) - Metabolic surgery – surgery of obesity
MUDr. Pavol Holéczy, CSc.
(1/2016, Topic of the year ) - Diabetes and obesity (diabesity) and COVID-19
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(4/2022, Topic of the year ) - Antiatherogenic effect and cardiovascular benefit of GLP-1 receptor´s agonists
doc. MUDr. Štefan Farský, CSc., FESC
(4/2022, Drugs & drug classes ) - Efficiency and safety of linagliptin – relevance to clinical practice
doc. MUDr. Martin Prázný, CSc., Ph.D., MUDr. Jan Šoupal
(2/2014, Review articles ) - Správa zo XIV. slovenských obezitologických dní s medzinárodnou účasťou
MUC. Michal Pečík
(5/2016, Events ) - Relative safety of new obesity drugs: latest evidence and patient management
MUDr. Ľubomíra Fábryová, PhD.
(2/2017, Topic of the year ) - Metabolické ochorenia – čoraz väčšia výzva pre výskum i klinickú prax
MUDr. Fábryová Ľubomíra, PhD.
(5/2012, Editorial ) - Artériová hypertenzia: klinické a výskumné trendy 2015. XIII. sympózium o artériovej hypertenzii v Prahe (Česká republika)
doc. MUDr. Marian Sninčák, CSc., mim. prof.
(3/2015, Events ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - INCRETINS, INCRETIN EFFECT AND DIABETES MELLITUS
MUDr. Adriana Ilavská
(S4/2007, Supplement ) - Metabolic changes after bariatric surgery
MUDr. Pavol Holéczy, CSc., Mgr. Marek Bužga, PhD.
(2/2016, Topic of the year ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - New possibilities of treatment of type 2 diabetes mellitus
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(3-4/2014, Review articles ) - GLP-1 receptor agonists in therapy of obesity
doc. MUDr. Zbynek Schroner, PhD.
(2/2022, Drugs & drug classes ) - News in pharmacological treatment of obesity/diabesity
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(5/2022, Topic of the year ) - Metformin – current position in the treatment of type 2 diabetes mellitus and discussed questions of its using
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(4/2015, Review articles ) - Weight loss pharmacotherapy of obese non-diabetic and type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(6/2015, Topic of the year ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - INSULIN – STILL THE ONLY RESCUE FOR PEOPLE WITH TYPE 1. DIABETES
MUDr. Ľubomír Barák, CSc.
(5/2005, Topic ) - Sitagliptine – representative of the new group of drugs indicated in the treatment of type 2 diabetes mellitus
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(4/2010, Drugs & drug classes ) - NOVEL INSULINS – ANALOGS IN TYPE 2 DM TREATMENT
doc. MUDr. Emil Martinka, PhD.
(7-8/2008, Topic ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic ) - Diabetes and heart failure
prof. MUDr. Ján Murín, CSc., doc. MUDr. Jozef Bulas, CSc.
(1/2014, Review articles ) - SPRÁVA Z XVIII. DIABETOLOGICKÝCH DNÍ 28. – 30. MÁJ 2008, KOŠICE
MUDr. Slávka Kalinová, PhD.
(7-8/2008, Events ) - Metabolic surgery in the treatment algorithm of obese type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(1/2017, Topic of the year ) - Diabesity, an increasing medical problem – diabetologist must be therefore also an obesitologist
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Mesárošová, PhD.
(4/2016, Topic of the year ) - Possibilities of prevention of type 2 diabetes mellitus in individuals with prediabetic dysglycemias
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(4/2016, Review articles ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(3/2008, Topic ) - The most significant news of the year 2023 in the pharmacology management of obesity
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(2/2024, Topic of the year )
- COMPARISON OF THE COST OF TREATMENT OF MAJOR DEPRESSIVE EPIZODE WITH ESCITALOPRAM AND A GENERIC CITALOPRAM BY MEANS OF A PHARMACOECONOMIC MODEL
doc. MUDr. Václav Filip, CSc., prof. RNDr. Jaromír Antoch, DrSc., MUDr. Jaroslava Skopová
(3/2005, Review articles )
- Diabetes mellitus: současný pohled na patogenezi, klasifikaci a léčbu
prof. MUDr. Michal Anděl, CSc.
(1/2007, From the boundary of neurology ) - Osteoporosis and vertebrogenic pain syndrome
doc. MUDr. Zdenko Killinger, PhD., MUDr. Daniel Čierny, PhD., MUDr. Kristína Brázdilová, PhD., prof. MUDr. Juraj Payer, CSc., FRCP
(5/2015, Main topic ) - Alzheimer’s disease and type 2 diabetes mellitus
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(2/2012, From the boundary of neurology )
- Glucocorticoid-induced osteoporosis in children – prevention and treatment
prof. MUDr. Ľudmila Podracká, CSc., MUDr. Kristína Kubejová
(3/2013, Review articles ) - What should the paediatrician know about precocious puberty
RNDr. Daniela Zemková, CSc., doc. MUDr. Marta Šnajderová, CSc.
(5/2010, Review articles ) - Influenza – vaccination is basis of prevention
prof. MUDr. Jiří Beran, CSc.
(6/2010, Review articles ) - CFRD – Cystic Fibrosis Related Diabetes
MUDr. Jaroslava Orosová, MUDr. Nina Bližnáková, MUDr. Ingrid Mikulášová, doc. MUDr. Vladimír Pohanka, PhD., MPH, FCCP
(6/2016, Review articles )
- The combination of systemic therapy and transarterial chemoembolization in the treatment of symptomatic hepatic metastases of malignant insulinoma
MUDr. Iveta Kopecká, PhD., MUDr. Marián Streško, PhD., MUDr. Abdullah Dammak, MUDr. Viera Skarbová, MUDr. Andrej Klepanec, PhD.
(6/2014, Original articles & case reports ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - LHRH analogs in treatment of breast cancer
MUDr. Ján Rajec, PhD., MUDr. Lucia Dzurillová
(3/2015, Review articles ) - Systemic therapy of gastroenteropancreatic neuroendocrine tumors
MUDR. Tomáš Šálek
(5/2017, Main topic ) - SYSTEMIC THERAPY OF NEUROENDOCRINE TUMORS
MUDr. Tomáš Šálek
(4/2006, Review articles ) - Neuroendocrine tumors from oncologist's point of view
doc. MUDr. Mária Wagnerová, CSc.
(4/2011, Review articles ) - Treatment and prognosis of patients with hairy cell leukaemia treated in 1996 – 2010 at the National Cancer Institute in Bratislava
MUDr. Miriam Ladická, MUDr. Ľudmila Demitrovičová, MUDr. Radoslav Greksák, PhD., MUDr. Iveta Oravcová, PhD.
(4/2011, Original articles & case reports ) - WALDENSTRÖM‘S MACROGLOBULINEMIA – EPIDEMIOLOGY, ETHIOPATOGENESIS, DIAGNOSTIC AND TREATMENT
prof. MUDr. Elena Tóthová, CSc.
(5/2008, Review articles ) - THERAPY FOR GLIOBLASTOMA MULTIFORME WITH CONCOMITANT CHEMRADIOTHERAPY AND FOLLOWING CHEMOTHERAPY
doc. MUDr. Igor Andrašina, CSc.
(4/2006, Review articles ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Pheochromocytoma and paraganglioma
MUDr. Mária Rečková
(2/2013, Main topic ) - PET findings in rare prostate cancers – neuroendocrine prostate cancer – case report
MUDr. Andrej Vondrák, prof. MUDr. Ján Kliment, CSc., MUDr. Jozef Kubinyi, PhD, FEBNM
(4/2020, Case reports ) - Conservative treatment of rare thoracic tumors – thymoma and carcinoid
MUDr. Mária Černá, CSc.
(6/2011, Review articles )
- Old drugs in new clothes: possibilities of using nanotechnology in the therapy of psoriasis
MUDr. Natália Andrýsková
(1/2023, Topic of the year )
- Perorální antidiabetika – současnost
prof. MUDr. Jindřiška Perušičová, DrSc.
(1/2009, Drugs & drug classes ) - DIABETES MELLITUS TYPE 2 TREATMENT – ORAL ANTIDIABETIC AGENTS
MUDr. Pavlína Piťhová
(2/2007, clearly ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(2/2008, Review articles )
- News in pharmacological treatment of obesity/diabesity
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(2/2023, Current pharmacotherapy ) - Nové liečivá v EÚ registrované v roku 2014 (II.)
Mgr. Zuzana Šestáková, PharrmDr. Peter Stanko
(2/2015, New drugs ) - The 42nd Days of Pharmacy with main topic „Diabetes“ – epidemic of the third millennium
doc. RNDr. Magdaléna Fulmeková, CSc.
(2/2016, Events ) - Victoza (liraglutid)
MUDr. Jitka Jurková
(3/2011, New medicinal substances ) - Sitagliptin
Ondřej Krystyník
(1/2011, New medicinal substances ) - Nové liečivá v EÚ registrované v roku 2013 (III.)
PharmDr. Peter Stanko
(2-3/2014, New drugs ) - Nové liečivá v EÚ registrované v roku 2013 (I.)
PharmDr. Peter Stanko
(4/2013, New drugs ) - Starostlivosť lekárnika o pacientov s diabetom
PharmDr. Marcel Jusko, PhD.
(2/2013, For pharmaceutical laboratory technicians )
- Periférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko – možnosti ovplyvnenia v klinickej praxi
MUDr. Denisa Čelovská, PhD., prof. MUDr. Viera Štvrtinová, CSc., MUC. Mária Balgová
(1/2018, Main topic ) - XIX. SLOVENSKO-ČESKÁ KONFERENCIA O HEMOSTÁZE A TROMBÓZE S MEDZINÁRODNOU ÚČASŤOU
(S2/2012, Supplement )
- Melatonin and its potential use in anesthesiology and intensive care
MUDr. Peter Čandík, PhD., doc. MUDr. Pavol Török, CSc., MUDr. Viktória Kováčová, MUDr. Boris Bilý, PhD., doc. MUDr. František Sabol, PhD., MPH
(1/2016, Review articles ) - Melatonin and its potential use in anesthesiology and intensive care
MUDr. Peter Čandík, PhD., doc. MUDr. Pavol Török, CSc., MUDr. Adrián Kolesár, PhD., MUDr. Viktória Kováčová, MUDr. Boris Bilý, PhD., doc. MUDr. František Sabol, PhD., MPH
(1/2016, Review articles )